SANUWAVE Health, Inc. (SNWV) EPS Estimated At $-0.02

July 14, 2018 - By Vernon Rice

SANUWAVE Health, Inc. (OTCMKTS:SNWV) Logo

Analysts expect SANUWAVE Health, Inc. (OTCMKTS:SNWV) to report $-0.02 EPS on August, 13.They anticipate $0.01 EPS change or 100.00 % from last quarter’s $-0.01 EPS. After having $-0.02 EPS previously, SANUWAVE Health, Inc.’s analysts see 0.00 % EPS growth. The stock decreased 5.60% or $0.022 during the last trading session, reaching $0.368. About 47,987 shares traded. SANUWAVE Health, Inc. (OTCMKTS:SNWV) has 0.00% since July 14, 2017 and is . It has underperformed by 12.57% the S&P500.

SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic pressure shockwaves for regenerative medicine and other applications. The company has market cap of $55.86 million. The Company’s shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It currently has negative earnings. The company's lead product candidate is the dermaPACE device, which has completed its initial Phase III, IDE clinical trial for treating diabetic foot ulcers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.